Daxor Corporation

NasdaqCM:DXR

Sector

🏥 Health Care

Industries

🩺 Medical Instruments

🔬 Clinical Trials

💻 Telehealth

Location

United States

Market Cap

USD 47.76 M

Share Price

USD 9.62

Avg Daily Volume

5,741

Change (1 day)

2.50%

Change (1 year)

0.36%

Change (YTD)

25.16%

Daxor Corporation Gross Profit Margin for the Trailing 12 Months (TTM) ending December 31, 2024

Daxor Corporation Gross Profit Margin is NA for the Trailing 12 Months (TTM) ending December 31, 2024. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Gross Profit Margin	EBIT Margin	EBITDA Margin	Net Income Margin

NasdaqCM: DXR

Daxor Corporation

CEO	Mr. Michael Richard Feldschuh
IPO Date	July 25, 1983
Location	United States
Headquarters	109 Meco Lane
Employees	37
Sector	🏥 Health Care
Industries Medical Instruments 🔬 Clinical Trials 💻 Telehealth

Description

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.